SCOPUS 정보 검색 플랫폼

Anticancer Research

Volumn 21, Issue 5, 2001, Pages 3209-3214

Sequence dependence of Alimta™ (LY231514, MTA) combined with doxorubicin in ZR-75-1 human breast carcinoma cells

(2) Schultz, Richard M a Dempsey, Jack A a

a ELI LILLY AND COMPANY (United States)

Author keywords

Alimta ; Breast cancer; Chemotherapy; Combination; Doxorubicin; Multitargeted antifolate

Indexed keywords

DNA; DOXORUBICIN; PEMETREXED;

ARTICLE; BREAST CARCINOMA; CANCER INHIBITION; CARCINOMA CELL; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; CYTOSTASIS; DRUG MECHANISM; DRUG POTENTIATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CELL CYCLE; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; DRUG SYNERGISM; GLUTAMATES; GROWTH INHIBITORS; GUANINE; HUMANS; TUMOR CELLS, CULTURED;

EID: 0035569915 PISSN: 02507005 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (5)

References (16)

1
- 0026494947
- A dideazatetrahydrofolate analogue lacking a chiral center a C-6, N-{4-[2-(2-amino-1,7-dihydro-4-oxopyrrolo [2,3-d]pyrimidine-6-yl)ethyl]benzoyl}glutamic acid, a new and potent inhibitor of thymidylate synthase
- (1992) J Med Chem , vol.35 , pp. 4450-4454
- Taylor, E.C.¹ Kuhnt, D.² Shih, C.³ Rinzel, S.M.⁴ Grindey, G.B.⁵ Barredo, J.⁶ Jannatipour, M.⁷ Moran, R.G.⁸

2
- 0030891198
- LY231514, a pyrrolo[2,3-d]pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes
- (1997) Cancer Res , vol.57 , pp. 1116-1123
- Shih, C.¹ Chen, V.J.² Gossett, L.S.³ Gates, S.B.⁴ MacKellar, W.C.⁵ Habeck, L.L.⁶ Shackelford, K.A.⁷ Mendelsohn, L.G.⁸ Soose, D.J.⁹ Patel, V.F.¹⁰ Andis, S.L.¹¹ Bewley, J.R.¹² Rayl, E.A.¹³ Moroson, B.A.¹⁴ Beardsley, G.P.¹⁵ Kohler, W.¹⁶ Ratnam, M.¹⁷ Schultz, R.M.¹⁸

3
- 0032914341
- Biological activity of the multitargeted antifolate, MTA (LY231514), in human cell lines with different resistance mechanisms to antifolate drugs
- (1999) Sem Oncol , vol.26 , Issue.SUPPL. C , pp. 68-73
- Schultz, R.M.¹ Chen, V.J.² Bewley, J.R.³ Roberts, E.F.⁴ Shih, C.⁵ Dempsey, J.A.⁶

4
- 0031730802
- Role of folic acid in modulating the toxicity and efficacy of the multitargeted antifolate, LY231514
- (1998) Anticancer Res , vol.18 , pp. 3235-3240
- Worzalla, J.F.¹ Shih, C.² Schultz, R.M.³

5
- 0028849683
- Initial phase I evaluation of the novel thymidylate synthase inhibitor, LY231514, using the modified continual reassessment method for dose escalation
- (1995) J Clin Oncol , vol.13 , pp. 2842-2850
- Rinaldi, D.A.¹ Burris, H.A.² Dorr, F.A.³ Woodworth, J.R.⁴ Kuhn, J.G.⁵ Eckardt, J.R.⁶ Rodriguez, G.⁷ Corso, S.W.⁸ Fields, S.M.⁹ Langley, C.¹⁰ Clark, G.¹¹ Faries, D.¹² Lu, P.¹³ VanHoff, D.D.¹⁴

6
- 0001045163
- Phase II study of MTA (LY231514) in patients with locally recurrent or metastatic breast cancer (LR/MBC)
- (1998) Proc Amer Soc Clin Oncol , vol.17
- Lind, M.J.¹ Smith, I.E.² Coleman, R.E.³ Calvert, A.H.⁴ Patel, M.⁵ Miles, D.W.⁶

7
- 0003201367
- MTA (multitargeted antifolate, LY231514) in metastatic breast cancer patients with prior anthracycline exposure: A European phase II study
- (1999) Proc Amer Soc Clin Oncol , vol.18
- Martin, M.¹ Spielmann, M.² Namer, M.³ Mollenkopf, A.⁴ Unger, C.⁵ Dodwell, D.⁶

8
- 0000267258
- Activity of MTA (Multitargeted Antifolate, LY231514) in metastatic breast cancer (MBC) patients previously treated with an anthracycline and a taxane
- (1999) Breast Cancer Res Treat , vol.57 , pp. 123
- Spielmann, M.¹ Martin, M.² Hamer, M.³ Mollenkopf, A.⁴ Unger, C.⁵ Dodwell, D.⁶

9
- 0000636287
- Pemetrexed disodium (ALIMTATM, LY231514, MTA) in locally advanced or metastatic breast cancer (MBC) patients (Pts) with prior anthracycline or anthracenedione and taxane treatement: Phase II study
- (2000) Proc Am Soc Clin Oncol , vol.19
- Theodoulou, M.¹ Llombart, A.² Cruciani, G.³ Bloch, R.⁴

10
- 0018079661
- Establishment and characterization of three new continuous cell lines derived from human breast carcinomas
- (1978) Cancer Res , vol.38 , pp. 3352-3364
- Engel, L.W.¹ Young, N.A.² Tralka, T.S.³ Lippman, M.E.⁴ O'Brien, S.J.⁵ Joyce, M.J.⁶

11
- 0021061819
- Rapid colorimetric assay for cellular growth and survivalc Application to proliferation and cytotoxicity assays
- (1983) J Immunol Methods , vol.65 , pp. 55-63
- Mosmann, T.¹

12
- 0002658306
- The median-effect principle and the combination index for quantitation of synergism and antagonism
- Chou T-C, Rideout D C (eds). Academic Press, San Diego
- (1991) Synergism and Antagonism in Chemotherapy , pp. 61-102
- Chou, T.-C.¹

13
- 0002454641
- Preclinical pharmacology studies and the clinical development of a novel multitargeted antifolate, MTA (LY231514)
- Jackman A L (ed). Humana Press, Totowa, NJ
- (1999) Antifolate Drugs in Cancer Therapy , pp. 183-201
- Shih, C.¹ Thornton, D.E.²

14
- 0032964203
- MTA (LY231514) in combination treatment regimens using human tumor xenografts and the EMT-6 murine mammary carcinoma
- (1999) Sem Oncol , vol.26 , pp. 55-62
- Teicher, B.A.¹ Alvarez, E.² Liu, P.³ Lu, K.⁴ Menon, K.⁵ Dempsey, J.⁶ Schultz, R.M.⁷

15
- 0015069924
- Interaction of some daunomycin derivatives with deoxyribonucleic acid and their biological activity
- (1971) Biochem Pharmacol , vol.20 , pp. 1323-1328
- DiMarco, A.¹ Zunino, F.² Silvestrini, R.³ Gambarucci, C.⁴ Gambetto, R.A.⁵

16
- 0015296175
- Lethal effect of adriamycin on the division of Hela cells
- (1972) Cancer Res , vol.32 , pp. 323-325
- Kim, S.H.¹ Kim, J.H.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.